Kim M. Cecil, PhD, serves as faculty in the Department of Radiology at Cincinnati Children’s Hospital Medical Center and as a Professor of Radiology, Pediatrics, Neuroscience, Environmental and Public Health Sciences at the University of Cincinnati College of Medicine. Her research efforts focus on the application of magnetic resonance spectroscopy and imaging in pediatric brain disorders and evaluating the effects of known and suspected environmental neurotoxicants on brain development.
In 2000, Dr. Cecil, Antonius deGrauw, MD, PhD and Gajja Salomons, PhD, discovered creatine transporter deficiency syndrome, a disorder caused by mutations in the creatine transporter gene. Male patients demonstrate a significant reduction or absence of creatine in the brain, as indicated by magnetic resonance spectroscopy. This is an X-linked mental retardation disorder thought to be second only to Fragile X in prevalence.
Her initial work while a post-doctoral fellow at the University of Pennsylvania evaluating pediatric lead exposure with spectroscopy eventually connected her to the Cincinnati Lead Study. These studies helped develop an emerging field combining noninvasive, human imaging with pediatric environmental epidemiology.
Kim M. Cecil, PhD, serves as faculty in the Department of Radiology at Cincinnati Children’s Hospital Medical Center and as a Professor of Radiology, Pediatrics, Neuroscience, Environmental and Public Health Sciences at the University of Cincinnati College of Medicine. Her research efforts focus on the application of magnetic resonance spectroscopy and imaging in pediatric brain disorders and evaluating the effects of known and suspected environmental neurotoxicants on brain development.
In 2000, Dr. Cecil, Antonius deGrauw, MD, PhD and Gajja Salomons, PhD, discovered creatine transporter deficiency syndrome, a disorder caused by mutations in the creatine transporter gene. Male patients demonstrate a significant reduction or absence of creatine in the brain, as indicated by magnetic resonance spectroscopy. This is an X-linked mental retardation disorder thought to be second only to Fragile X in prevalence.
Her initial work while a post-doctoral fellow at the University of Pennsylvania evaluating pediatric lead exposure with spectroscopy eventually connected her to the Cincinnati Lead Study. These studies helped develop an emerging field combining noninvasive, human imaging with pediatric environmental epidemiology.